UNSPSC 85812614: Introduction of monoclonal antibody into mouth and pharynx, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of monoclonal antibody into mouth and pharynx, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0D30M

UNSPSC 85812614, Introduction of monoclonal antibody into mouth and pharynx, percutaneous approach, is a Commodity code showing minimal relevant recent activity in state and local procurement. The code's clinical specificity—a medical procedure for delivering monoclonal antibodies via percutaneous injection into oral or pharyngeal tissues—does not align with the opportunities posted under it. Recent state and local solicitations tagged with this code are pursuing virtual urgent care services, occupational health exams, cancer registry work, retinal screening devices, EMS staffing, employee wellness programs, and related health services; none of these solicitations require or reference the procedure the code nominally describes.

State and local procurement bodies do not appear to be sourcing this specific procedure as a standalone service through competitive solicitation. The mismatch between the code's narrow clinical definition and the broad operational health services being solicited suggests either misclassification of opportunities by issuing bodies or minimal demand for this particular intervention at the state and local level. Firms evaluating this code should note that bidding activity is not concentrated in any particular jurisdiction or service model—the code does not surface decision-relevant procurement signals at this time.